DLBCL ncMO were enriched for both inflammatory (CXCL10, AIM2, IL12A) and tolerogenic (PDCD1LG2, IL10, IDO, CD274, AGER) genes (P <.05, ∣log2FC∣ > 1) compared to cMO and iMO (Figure 3C). This evidence concerns the gene PDCD1LG2 and diffuse large B-cell lymphoma.